US-based biotechnology firm Aldatu Biosciences has confirmed that its PANDAA qDx SARS-CoVar test kit has the ability to detect and differentiate between Omicron, Delta and all other Covid-19 variants of concern.
Designed as a reflex test on positive RNA, the new SARS-CoV-2 Variant Genotyping Test kit can differentiate five Covid-19 variants of concern, including Omicron.
It can also differentiate three variants of interest and the non-variant Wuhan strain of the virus.
The assay uses the focused genotyping approach on the SARS-CoV-2 S gene, which is more cost-effective in comparison to sequencing for Covid-19 variant genotyping.
Because each variant of concern has a different fluorescent signature, the test kit uses fluorescent probes in two multiplex PANDAA reactions.
This allows the variants to be differentiated accurately down to 100 copies/ml.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The PANDAA qDx SARS-CoVar test kit provides accurate results from RNA in one hour.
Aldatu Biosciences chief business officer Mike Henry said: “Our focused genotyping approach of the S gene of CoV-2 is faster and more affordable than sequencing if you wish to know which strain of the virus is present in an individual or a population.
“Our test is fast, delivering fast results in less than one-hour from RNA, highly sensitive and available for purchase now.
“And, in response to the current testing needs, we can guarantee 24-hour shipping. The test is platform-agnostic, meaning it is compatible with sample prep and qPCR platform in most labs.”
Recently, PerkinElmer announced the launch of its NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to accelerate SARS-CoV-2 variants detection.
The new research use only (RUO) test kit will help laboratories increase sequencing throughput and reliably identify Covid-19 variants.